EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

June 7, 2022

Study Completion Date

August 16, 2025

Conditions
Abdominal Aortic Aneurysm Without Rupture
Interventions
DEVICE

Nellix® System

Endovascular Abdominal Aortic Aneurysm Repair using the Nellix® System

Trial Locations (27)

10029

Icahn School of Medicine at Mount Sinai, New York

20010

MedStar Health Research Institute, Washington D.C.

22042

Inova Research Center, Falls Church

29203

Palmetto Health- University of South Carolina, Columbia

32503

Coastal Vascular & Interventional, Pensacola

32803

AdventHealth Orlando, Orlando

33176

Miami Cardiac & Vascular Institute (MCVI), Miami

35801

Valley Vascular Consultants, Huntsville

37660

Wellmont CVA Heart Institute, Kingsport

38120

Cardiovascular Surgery Clinic, Memphis

44095

Northeast Ohio Vascular Assoc (NEOVA), Willoughby

44195

Cleveland Clinic, Cleveland

46290

St. Vincent Heart Center of Indiana, Indianapolis

48708

McLaren Bay Region, Bay City

54401

Aspirus Research Institute, Wausau

60007

AMITA Health, Elk Grove Village

61820

Christie Clinic, Champaign

64116

Midwest Aortic & Vascular Institute, Kansas City

74135

OU College of Medicine, Tulsa

80909

UC Health-Memorial Hospital, Colorado Springs

87102

New Mexico Heart Institute, Albuquerque

90095

Regents of the University of California (UCLA), Los Angeles

92161

Veterans Medical Research Foundation, San Diego

97213

Providence St. Vincent Medical Center, Portland

99204

Providence Sacred Heart Medical Center, Spokane

02114

Massachusetts General Hospital, Boston

08103

The Cooper Health System, Camden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Endologix

INDUSTRY